STORY
4 days 3 outlets 5 reports running since 19.08

LATEST

Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story
finance.yahoo.com  ·  23.08.2026 08:23

HOW IT DEVELOPED

  1. Moderna Soars as Vaccine-Drug Combo Slows Recurrence of Melanoma finance.yahoo.com  ·  20.08 06:01
  2. Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations finance.yahoo.com  ·  19.08 23:58
  3. mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say arstechnica.com  ·  19.08 18:53
  4. Moderna share price doubles on melanoma vaccine trial success ft.com  ·  19.08 14:08